>
pdufa.bio

Atumelnant

Updated ยทnext FDA decision on the calendar

Atumelnant is a Crinetics Pharmaceuticals, Inc. program. Its next catalyst is a Readout in Jul 2029. Every date links its source.

CRNX catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Crinetics Pharmaceuticals, Inc. (CRNX). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jul 2029CRNX

Questions

When is Atumelnant's next FDA decision or readout?

The next tracked catalyst for Atumelnant is a Readout in Jul 2029.

What happened at Atumelnant's most recent FDA decision?

No FDA decision for Atumelnant is in our archive yet.

Who makes Atumelnant?

Crinetics Pharmaceuticals, Inc. (CRNX).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.